person

Stanislas D.

Country
France
Department
Radiologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 2 partner sites.

Specializations

Solid Tumor Oncology

The investigator concentrates on advanced solid tumors, emphasizing personalized therapeutic strategies for thoracic, gastrointestinal and genitourinary malignancies.

  • Non‑small cell lung cancer (NSCLC)
  • Renal cell carcinoma (RCC)
  • Hepatocellular carcinoma (HCC)
  • Pancreatic adenocarcinoma

Radiologic assessment integrates response evaluation and biomarker‑driven trial enrollment.

Hematologic Malignancies

Focused on aggressive hematologic cancers, the investigator evaluates novel agents for both myeloid and lymphoid disorders.

  • Acute myeloid leukemia (AML)
  • Chronic lymphocytic leukemia (CLL)
  • Multiple myeloma
  • Diffuse large B‑cell lymphoma (DLBCL)

Imaging techniques support disease staging and treatment monitoring.

Infectious Respiratory Diseases

Research includes complex pulmonary infections where imaging guides diagnosis and therapeutic decisions.

  • Nontuberculous mycobacterial (NTM) lung infection
  • Bronchiectasis with chronic Pseudomonas colonization
  • Severe asthma with eosinophilic phenotype

Advanced CT and MRI protocols are employed to track disease progression.

Cardiovascular and Metabolic Disorders

Investigations address high‑risk cardiovascular conditions and metabolic syndromes prevalent in the adult population.

  • Obstructive sleep apnea (OSA)
  • Atherosclerotic cardiovascular disease (ASCVD)
  • Hypertension with chronic kidney disease
  • Obesity‑related metabolic dysfunction

Imaging biomarkers are utilized to stratify risk and evaluate therapeutic impact.

Autoimmune and Systemic Inflammatory Conditions

The investigator explores immune‑mediated diseases, integrating radiologic biomarkers with targeted therapies.

  • Systemic lupus erythematosus (SLE) and lupus nephritis
  • ANCA‑associated vasculitis
  • Rheumatoid arthritis (RA)
  • Inflammatory bowel disease (Crohn’s disease, ulcerative colitis)

Cross‑modality imaging assists in disease activity assessment and treatment response.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.